These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1356348)

  • 21. Cytotoxic T-lymphocyte induction in asymptomatic HIV-1-infected patients immunized with Retrovector-transduced autologous fibroblasts expressing HIV-1IIIB Env/Rev proteins.
    Ziegner UH; Peters G; Jolly DJ; Mento SJ; Galpin J; Prussak CE; Barber JR; Hartnett DE; Bohart C; Klump W
    AIDS; 1995 Jan; 9(1):43-50. PubMed ID: 7893440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
    Woffendin C; Yang ZY; Udaykumar ; Xu L; Yang NS; Sheehy MJ; Nabel GJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11581-5. PubMed ID: 7972106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes.
    Gruters RA; van Baalen CA; Osterhaus AD
    Vaccine; 2002 May; 20(15):2011-5. PubMed ID: 11983265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
    Bevec D; Dobrovnik M; Hauber J; Böhnlein E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
    Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
    Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocyte recognition of HLA-B*5101-restricted HIV-1 Rev epitope which is naturally processed in HIV-1-infected cells.
    Tomiyama H; Chujoh Y; Shioda T; Miwa K; Oka S; Kaneko Y; Takiguchi M
    AIDS; 1999 May; 13(7):861-3. PubMed ID: 10357388
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.
    Adams M; Sharmeen L; Kimpton J; Romeo JM; Garcia JV; Peterlin BM; Groudine M; Emerman M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3862-6. PubMed ID: 8171003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.
    Gougeon ML; Montagnier L
    Ann N Y Acad Sci; 1999; 887():199-212. PubMed ID: 10668476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of HIV-1 gene expression and transcription.
    Baba M
    Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.
    Scott ZA; Beaumier CM; Sharkey M; Stevenson M; Luzuriaga K
    J Immunol; 2003 Jun; 170(11):5786-92. PubMed ID: 12759463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell dynamics in HIV-1 infection.
    Douek DC; Picker LJ; Koup RA
    Annu Rev Immunol; 2003; 21():265-304. PubMed ID: 12524385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
    Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
    Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus.
    Etemad-Moghadam B; Rhone D; Steenbeke T; Sun Y; Manola J; Gelman R; Fanton JW; Racz P; Tenner-Racz K; Axthelm MK; Letvin NL; Sodroski J
    J Virol; 2001 Jun; 75(12):5646-55. PubMed ID: 11356972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of human immunodeficiency virus-1 latency and its reactivation.
    Verdin E
    Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
    Wu BY; Woffendin C; Duckett CS; Ohno T; Nabel GJ
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1480-4. PubMed ID: 7878004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    van Baalen CA; Pontesilli O; Huisman RC; Geretti AM; Klein MR; de Wolf F; Miedema F; Gruters RA; Osterhaus AD
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1913-8. PubMed ID: 9266987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.